Mapping features and patterns of accelerometry data on human movement in different age groups and associated health problems: A cross-sectional study.

PURPOSE: Human movement is considered one of the important factors for maintaining an independent life. Individuals in different age groups have different characteristics of locomotion patterns and some health conditions can affect or be affected by mobility changes. Few studies clarify or present data about the influence of different ages and biopsychosocial factors on accelerometry features. The aim of this study was to identify characteristics and variables in the frequency signals for different age groups and their relationship with associated health conditions in raw accelerometry data obtained from the use of a triaxial accelerometer during 7 days of activities of daily living. METHOD: A cross-sectional study was conducted based on the database of the first evaluations of the Epidemiological Study of Movement (EPIMOV) cohort. Frequency, signal amplitude, and entropy accelerometry features of EPIMOV participants who used a triaxial accelerometer for 7 days were extracted. Sociodemographic, clinical, anthropometric and physical activity assessments were also performed. Two-way ANOVA was performed to compare accelerometry features within different age groups. A series of stepwise multiple regressions were performed on accelerometry variables to analyze their relationships with demographic, anthropometric and cardiovascular risk variables. RESULTS: The sample consisted mostly of female, white, and high school graduates. The most prevalent cardiovascular risk factors were sedentary behavior and obesity. When analyzing the accelerometry variables, it was possible to observe that the entropy feature, and the counts, decrease in the group of older adults, while the feature of harmonic components of gait (frequency × amplitude) increases in the group of older adults. Regarding the amplitude feature, there were no significant differences between the groups. Through stepwise multiple linear regression, it was possible to observe that demographic, anthropometric and cardiovascular risk factors are associated with most accelerometry variables. CONCLUSION: The results confirm that human movement can be influenced by different ages, sex, demographic, anthropometric and cardiovascular risk factors. Future studies and clinical analyzes can use the methods proposed in this research to adjust movement patterns for sex and different age groups, thus obtaining new interpretations about human movement.

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease.

BACKGROUND: Cannabidiol (CBD) is one of the main components of Cannabis sativa and has anxiolytic properties, but no study has been conducted to evaluate the effects of CBD on anxiety signs and symptoms in patients with Parkinson's disease (PD). This study aimed to evaluate the impacts of acute CBD administration at a dose of 300 mg on anxiety measures and tremors induced by a Simulated Public Speaking Test (SPST) in individuals with PD. METHODS: A randomised, double-blinded, placebo-controlled, crossover clinical trial was conducted. A total of 24 individuals with PD were included and underwent two experimental sessions within a 15-day interval. After taking CBD or a placebo, participants underwent the SPST. During the test, the following data were collected: heart rate, systemic blood pressure and tremor frequency and amplitude. In addition, the Visual Analog Mood Scales (VAMS) and Self-Statements during Public Speaking Scale were applied. Statistical analysis was performed by repeated-measures analysis of variance (ANOVA) while considering the drug, SPST phase and interactions between these variables. RESULTS: There were statistically significant differences in the VAMS anxiety factor for the drug; CBD attenuated the anxiety experimentally induced by the SPST. Repeated-measures ANOVA showed significant differences in the drug for the variable related to tremor amplitude as recorded by the accelerometer. CONCLUSION: Acute CBD administration at a dose of 300 mg decreased anxiety in patients with PD, and there was also decreased tremor amplitude in an anxiogenic situation.